SB202190 FHPI size: 100 mg
SB202190 (FHPI) is a potent and selective p38 MAP kinase inhibitor widely used in cell signaling, apoptosis studies, inflammation research, and cancer biology. This high-purity inhibitor is supplied in a 100 mg vial, making it ideal for biochemical assays, kinase pathway analysis, and molecular pharmacology experiments.
